SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

2 Oct 2017 07:32

RNS Number : 3676S
Numis Corporation PLC
02 October 2017
 

2nd October 2017

Numis Corporation Plc

Trading Update

 

Monday 2nd October 2017 at 7.00am: Numis Corporation Plc ("Numis") today issued a trading update relating to the year ended 30th September 2017.

 

Our second half trading performance was very strong and recorded revenue 47% higher than the first half of 2017 and 38% higher than the second half of 2016. Consequently, full year revenue has grown by 15% versus prior year, and it is anticipated that profit will show similar levels of growth.

 

Our Corporate Broking & Advisory business ("CB&A") completed 98 transactions in total (2016: 86) which included equity fund raises totalling £2.5 billion, up 38% on prior year (2016: £1.8 billion). Revenue from CB&A activities has grown by 15% versus prior year.

 

Our Equities business performed well. Against a background of generally positive equity markets, combined institutional commission and trading revenues increased by 15% year-on-year. We continue to work closely with our institutional clients and believe the firm is well positioned as the implementation of MiFID II draws closer.

 

Numis will announce full preliminary results for the year ended 30th September 2017 on Wednesday 6th December 2017.

 

 

Alex Ham and Ross Mitchinson, Co-Chief Executive Officers, said:

 

"We are pleased to report that the second half was our best on record in terms of both revenue and operating profit. In addition, we have increased our focus on supporting unquoted companies and playing a key role in developing the capital markets which support them.

 

Our deal pipeline is strong and we remain determined to support ambitious companies of all sizes seeking capital and high quality advice to grow, whilst simultaneously investing in our people, platform and relationships. Whilst we cannot predict the direction of the market or the health of the equity issuance environment, there is good momentum in the business and we look forward to the future with confidence."

 

ENDS

 

 

Contacts

Numis Corporation:

Alex Ham & Ross Mitchinson 020 7260 1245

Co-Chief Executive Officers

 

 Brunswick:

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):Philip Secrett 020 7728 2578

Samantha Harrison 020 77865 2411Harrison J Clarke 020 7184 4384 

 

 

 

 

 

 

Notes for Editors

Numis is a leading independent corporate advisory and stockbroking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUUNRBKARRRA
Date   Source Headline
20th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Mar 201811:06 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20183:00 pmRNSDirectors' Dealing
9th Mar 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20184:00 pmRNSDirector's Dealing
23rd Feb 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20182:13 pmRNSHolding(s) in Company
15th Feb 201812:45 pmRNSHolding(s) in Company
13th Feb 20181:41 pmRNSHolding(s) in Company
13th Feb 201811:28 amRNSHolding(s) in Company
6th Feb 20181:17 pmRNSResult of AGM
6th Feb 20187:00 amRNSTrading update
5th Feb 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jan 201812:00 pmRNSDirectors' Dealing
16th Jan 20187:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 201811:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jan 20187:00 amRNSBoard Change
5th Jan 20189:14 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20187:00 amRNSAnnual Report and Annual General Meeting Notice
13th Dec 20173:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
6th Dec 20177:00 amRNSPreliminary Results for the year ended 30 Sep 2017
29th Nov 20174:28 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Nov 201711:32 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20177:32 amRNSTrading Update
29th Sep 20177:00 amRNSPurchase of Shares in Close Period
21st Sep 20177:00 amRNSCancellation of Share Premium Account
20th Sep 201711:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20173:00 pmRNSHolding(s) in Company
14th Sep 20177:00 amRNSDirector's Dealing
12th Sep 20173:00 pmRNSTransaction in Own Shares and Total Voting Rights
5th Sep 20174:32 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 20174:34 pmRNSTransaction in Own Shares and Total Voting Rights
4th Sep 201711:09 amRNSHolding(s) in Company
1st Sep 20172:24 pmRNSHolding(s) in Company
1st Sep 20172:23 pmRNSDirector's Dealing
1st Sep 201712:26 pmRNSTransaction in Own Shares and Total Voting Rights
30th Aug 201711:00 amRNSResult of General Meeting
11th Aug 20171:00 pmRNSNotice of Meeting and Proposed Capital Reduction
9th Aug 20173:34 pmRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20177:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jul 20177:01 amRNSBoard Changes
28th Jul 20177:00 amRNSTrading Update
13th Jul 201711:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.